ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
<p><strong>Objectives</strong></p> <p>The use of aspirin for the secondary prevention of cardiovascular disease (CVD) is firmly established, and the proportional reductions in heart attacks and strokes appear to be similar in people with and without diabetes. Uncertaint...
Main Authors: | , , , , , , , |
---|---|
Format: | Journal article |
Published: |
Elsevier
2017
|